These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 21425211)

  • 21. Role of MiRNAs in Inflammatory Bowel Disease.
    Cao B; Zhou X; Ma J; Zhou W; Yang W; Fan D; Hong L
    Dig Dis Sci; 2017 Jun; 62(6):1426-1438. PubMed ID: 28391412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases.
    Dai R; Ahmed SA
    Transl Res; 2011 Apr; 157(4):163-79. PubMed ID: 21420027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiRNA-Based Therapies for the Treatment of Inflammatory Bowel Disease: What Are We Still Missing?
    Innocenti T; Bigagli E; Lynch EN; Galli A; Dragoni G
    Inflamm Bowel Dis; 2023 Feb; 29(2):308-323. PubMed ID: 35749310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of micro-ribonucleic acid in disease development].
    Widjaya B; Seidelin JB; Olsen J; Nielsen OH
    Ugeskr Laeger; 2009 Nov; 171(47):3441-4. PubMed ID: 19925731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer.
    James JP; Riis LB; Malham M; Høgdall E; Langholz E; Nielsen BS
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional Implications of MicroRNAs in Crohn's Disease Revealed by Integrating MicroRNA and Messenger RNA Expression Profiling.
    Palmieri O; Creanza TM; Bossa F; Latiano T; Corritore G; Palumbo O; Martino G; Biscaglia G; Scimeca D; Carella M; Ancona N; Andriulli A; Latiano A
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28726756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysing miRNA-Target Gene Networks in Inflammatory Bowel Disease and Other Complex Diseases Using Transcriptomic Data.
    Thomas JP; Ölbei M; Brooks-Warburton J; Korcsmaros T; Modos D
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs in inflammatory bowel diseases: paradoxes and possibilities.
    Whiteoak SR; Felwick R; Sanchez-Elsner T; Fraser Cummings JR
    Inflamm Bowel Dis; 2015 May; 21(5):1160-5. PubMed ID: 25844960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The emerging role of miRNAs in inflammatory bowel disease: a review.
    Chapman CG; Pekow J
    Therap Adv Gastroenterol; 2015 Jan; 8(1):4-22. PubMed ID: 25553076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deep Dive Into MicroRNAs in Inflammatory Bowel Disease.
    Alfaifi J; Germain A; Heba AC; Arnone D; Gailly L; Ndiaye NC; Viennois E; Caron B; Peyrin-Biroulet L; Dreumont N
    Inflamm Bowel Dis; 2023 Jun; 29(6):986-999. PubMed ID: 36545755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of MicroRNAs during Inflammatory Bowel Disease: Effects on the Mucus Layer and Intercellular Junctions for Gut Permeability.
    Stiegeler S; Mercurio K; Iancu MA; Corr SC
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs and inflammation in the pathogenesis and progression of colon cancer.
    Okayama H; Schetter AJ; Harris CC
    Dig Dis; 2012; 30 Suppl 2(Suppl 2):9-15. PubMed ID: 23207927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of variations within microRNA in inflammatory bowel disease.
    Papaconstantinou I; Stamatis K; Tzathas C; Vassiliou I; Giokas G; Gazouli M
    Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):399-403. PubMed ID: 23466513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating microRNAs in Inflammatory Bowel Diseases.
    Gazouli M
    Exp Suppl; 2015; 106():197-214. PubMed ID: 26608205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sparse Modeling Reveals miRNA Signatures for Diagnostics of Inflammatory Bowel Disease.
    Hübenthal M; Hemmrich-Stanisak G; Degenhardt F; Szymczak S; Du Z; Elsharawy A; Keller A; Schreiber S; Franke A
    PLoS One; 2015; 10(10):e0140155. PubMed ID: 26466382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Potential relevance of microRNAs in the diagnostics of inflammatory bowel diseases].
    Igaz I; Szőnyi M; Varga P; Topa L
    Orv Hetil; 2014 Mar; 155(13):487-91. PubMed ID: 24659741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Micro-RNAs in inflammatory diseases and as a link between inflammation and cancer.
    Ranjha R; Paul J
    Inflamm Res; 2013 Apr; 62(4):343-55. PubMed ID: 23417288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating microRNAs as biomarkers for inflammatory diseases.
    Mi S; Zhang J; Zhang W; Huang RS
    Microrna; 2013; 2(1):63-71. PubMed ID: 25019052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of MicroRNA in Inflammatory Bowel Disease.
    Dalal SR; Kwon JH
    Gastroenterol Hepatol (N Y); 2010 Nov; 6(11):714-22. PubMed ID: 21437020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-Throughput Sequencing of microRNAs in Glucocorticoid Sensitive Paediatric Inflammatory Bowel Disease Patients.
    De Iudicibus S; Lucafò M; Vitulo N; Martelossi S; Zimbello R; De Pascale F; Forcato C; Naviglio S; Di Silvestre A; Gerdol M; Stocco G; Valle G; Ventura A; Bramuzzo M; Decorti G
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29738455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.